Drugs / CD8 Depleted Donor Lymphocyte
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT00038818 | May 2001 → Dec 2002 | Hodgkins lymphoma, chronic lymphocytic leukemia/small lymphocytic lymphoma, chronic myeloid leukemia, plasma cell myeloma | M.D. Anderson Cancer Center | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD8 Depleted Donor Lymphocyte | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00038818 ↗ |
| Modality | Cell therapy | “CD8 depleted DLI (Depleted Donor Lymphocyte Infusions)” NCT00038818 ↗ |